Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?

被引:9
|
作者
Zaveri, Mitul P. [1 ]
Perry, Jamal C. [2 ]
Schuetz, Tayna M. [2 ]
Memon, Mohammad D. [2 ]
Faiz, Sadaf [2 ]
Cancarevic, Ivan [1 ]
机构
[1] Calif Inst Behav Neurosci & Psychol, Internal Med, Fairfield, CA 94534 USA
[2] Calif Inst Behav Neurosci & Psychol, Med, Fairfield, CA USA
关键词
dilated cardiomyopthy; type 2 diabetes mellitus; diabetic cardiomyopathy; DILATED CARDIOMYOPATHY; OLMSTED COUNTY; HEART-FAILURE;
D O I
10.7759/cureus.11100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dilated cardiomyopathy (DCM) is a common form of cardiomyopathy that affects the cardiac muscle. It is a life-threatening condition that causes heart failure as it decreases the myocardial ability to pump sufficient blood throughout the body. Numerous causes trigger DCM without pathophysiology; however, the key concept is a decrease in the systolic function of either the left ventricle or of both the left and right ventricles. Long-term diabetes plays an important role in the pathogenesis of DCM in the form of diabetic cardiomyopathy. Diabetic cardiomyopathy is a non-ischemic form of DCM, which is associated with diabetes. It is unrelated to atherosclerosis and hypertension. The PubMed and Google Scholar databases were used to identify the relevant studies related to diabetes and DCM. We found that diabetes was associated with cardiac muscle injury by activating the renin-angiotensin-aldosterone system, myocardial inflammation, and fibrosis. Based on the available data, we concluded that there is strong evidence to support the interrelation of DCM and diabetes.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Potential clinical biomarkers and perspectives in diabetic cardiomyopathy
    Jianxin Deng
    Fang Yan
    Jinglun Tian
    Aijun Qiao
    Dewen Yan
    Diabetology & Metabolic Syndrome, 15
  • [32] IS THYROTOXIC CARDIOMYOPATHY AN ENTITY
    LUDERITZ, B
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 109 (06) : 203 - 204
  • [33] Focal hypermetabolic left ventricular cardiomyopathy: a new arrhythmogenic clinical entity?
    Porretta, A. P.
    Park, C. -I.
    Di Bernardo, S.
    Bisch, L.
    Schlaepfer, J.
    Pascale, P.
    Le Bloa, M.
    Buss, G.
    Prior, J.
    Pruvot, E.
    EUROPEAN HEART JOURNAL, 2017, 38 : 343 - 344
  • [34] Small pancreatic ductal adenocarcinoma: a true clinical entity or an invalid diagnostic myth
    Mohamed, Eyas
    Dodd, James
    Ghaneh, Paula
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 12 - 13
  • [35] Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies
    Tarquini, Roberto
    Pala, Laura
    Brancati, Simona
    Vannini, Giulia
    De Cosmo, Salvatore
    Mazzoccoli, Gianluigi
    Rotella, Carlo Maria
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (13) : 1510 - 1524
  • [36] Cirrhotic cardiomyopathy: A specific entity
    Brondex, A.
    Arles, F.
    Lipovac, A. -S.
    Richecoeur, M.
    Bronstein, J. -A.
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2012, 61 (02): : 99 - 104
  • [37] Peripartum cardiomyopathy: A multiple entity
    Vanzetto, Gerald
    Martin, Alix
    Bouvaist, Helene
    Marliere, Stephanie
    Durand, Michel
    Chavanon, Olivier
    PRESSE MEDICALE, 2012, 41 (06): : 613 - 620
  • [38] DIALYSIS CARDIOMYOPATHY - PATHOLOGICAL ENTITY
    MILNE, FJ
    LEWIN, J
    POULOS, PM
    MEYERS, AM
    CHATGIDAKIS, C
    SOUTH AFRICAN JOURNAL OF SURGERY, 1979, 17 (03) : 115 - 115
  • [39] DIALYSIS CARDIOMYOPATHY - PATHOLOGIC ENTITY
    MILNE, FJ
    LEWIN, J
    POULOS, PM
    MEYERS, AM
    CHATGIDAKIS, C
    KIDNEY INTERNATIONAL, 1979, 16 (01) : 89 - 89
  • [40] Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients: An Important but Underrecognized Clinical Entity
    te Riele, Anneline S. J. M.
    James, Cynthia A.
    Calkins, Hugh
    Tsatsopoulou, Adalena
    FRONTIERS IN PEDIATRICS, 2021, 9